Drug recall · June 24, 2020
Irinotecan HCL Injection recall
Why: Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01
- Lots / codes
Lot #:AC0231A, exp. date 08/2021
- Quantity
- 17,998 vials
- Company
- Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
- Distribution
- Nationwide within the United States
- Initiated
- June 11, 2020 · Voluntary: Firm initiated
- Classified
- June 12, 2020
- Reported
- June 24, 2020
- Ended
- June 10, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Irinotecan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.